SUNEEL KOUL: Open Payments
NPI 1881601276 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 72 payments from 10 companies in 2025. Trend: 2023 $613 · 2024 $1,101 · 2025 $1,313
Food & beverage: $1,313
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $284 |
| ABBVIE INC. | 17 | $279 |
| Novo Nordisk Inc | 16 | $268 |
| PFIZER INC. | 12 | $186 |
| Braeburn Inc. | 4 | $84 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 4 | $46 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: Ozempic, VRAYLAR, UBRELVY, BREZTRI, AIRSUPRA, PREVNAR 20, Rybelsus, BRIXADI.
Industry payments across NY — which companies pay providers there.
